241 related articles for article (PubMed ID: 8831755)
21. Sensitivity to taxoid derivatives of a newly established human endometrioid ovarian adenocarcinoma radioresistant cell line.
Griffon G; Merlin JL; Parache RM; Martinet N; Marchal S; Nabet F; Wellman M; Barlier C; Marchal C
Anticancer Res; 1996; 16(1):177-87. PubMed ID: 8615606
[TBL] [Abstract][Full Text] [Related]
22. Semi-synthesis of an O-glycosylated docetaxel analogue.
Nikolakakis A; Haidara K; Sauriol F; Mamer O; Zamir LO
Bioorg Med Chem; 2003 Apr; 11(7):1551-6. PubMed ID: 12628678
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of taxoids with improved cytotoxicity and solubility for use in tumor-specific delivery.
Miller ML; Roller EE; Zhao RY; Leece BA; Ab O; Baloglu E; Goldmacher VS; Chari RV
J Med Chem; 2004 Sep; 47(20):4802-5. PubMed ID: 15369381
[TBL] [Abstract][Full Text] [Related]
24. New highly active taxoids from 9beta-dihydrobaccatin-9,10-acetals. Part 3.
Takeda Y; Yoshino T; Uoto K; Chiba J; Ishiyama T; Iwahana M; Jimbo T; Tanaka N; Terasawa H; Soga T
Bioorg Med Chem Lett; 2003 Jan; 13(2):185-90. PubMed ID: 12482420
[TBL] [Abstract][Full Text] [Related]
25. Transport and cytotoxicity of paclitaxel, docetaxel, and novel taxanes in human breast cancer cells.
Ehrlichova M; Vaclavikova R; Ojima I; Pepe A; Kuznetsova LV; Chen J; Truksa J; Kovar J; Gut I
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):95-105. PubMed ID: 16059735
[TBL] [Abstract][Full Text] [Related]
26. Preclinical profile of docetaxel (taxotere): efficacy as a single agent and in combination.
Bissery MC; Vrignaud P; Lavelle F
Semin Oncol; 1995 Dec; 22(6 Suppl 13):3-16. PubMed ID: 8604451
[TBL] [Abstract][Full Text] [Related]
27. Butitaxel analogues: synthesis and structure-activity relationships.
Ali SM; Hoemann MZ; Aubé J; Georg GI; Mitscher LA; Jayasinghe LR
J Med Chem; 1997 Jan; 40(2):236-41. PubMed ID: 9003522
[TBL] [Abstract][Full Text] [Related]
28. Chemistry and chemical biology of taxane anticancer agents.
Miller ML; Ojima I
Chem Rec; 2001; 1(3):195-211. PubMed ID: 11895119
[TBL] [Abstract][Full Text] [Related]
29. [Studies on structure modification and structure-activity relationship of new taxoids derived from sinenxan a].
Huang G; Guo J; Liang X
Yao Xue Xue Bao; 1998 Aug; 33(8):576-86. PubMed ID: 12016896
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and SAR study of 3rd-generation taxoids bearing 3-CH
Wang C; Wang X; Sun Y; Taouil AK; Yan S; Botchkina GI; Ojima I
Bioorg Chem; 2020 Jan; 95():103523. PubMed ID: 31911305
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, and biological evaluation of new-generation taxoids.
Ojima I; Chen J; Sun L; Borella CP; Wang T; Miller ML; Lin S; Geng X; Kuznetsova L; Qu C; Gallager D; Zhao X; Zanardi I; Xia S; Horwitz SB; Mallen-St Clair J; Guerriero JL; Bar-Sagi D; Veith JM; Pera P; Bernacki RJ
J Med Chem; 2008 Jun; 51(11):3203-21. PubMed ID: 18465846
[TBL] [Abstract][Full Text] [Related]
32. Novel cytotoxic 3'-(tert-butyl) 3'-dephenyl analogs of paclitaxel and docetaxel.
Ali SM; Hoemann MZ; Aubé J; Mitscher LA; Georg GI; McCall R; Jayasinghe LR
J Med Chem; 1995 Sep; 38(19):3821-8. PubMed ID: 7562913
[TBL] [Abstract][Full Text] [Related]
33. Anti-proliferative activity of a new class of taxanes (14beta-hydroxy-10-deacetylbaccatin III derivatives) on multidrug-resistance-positive human cancer cells.
Distefano M; Scambia G; Ferlini C; Gaggini C; De Vincenzo R; Riva A; Bombardelli E; Ojima I; Fattorossi A; Panici PB; Mancuso S
Int J Cancer; 1997 Sep; 72(5):844-50. PubMed ID: 9311603
[TBL] [Abstract][Full Text] [Related]
34. In vitro evaluation of schedule-dependent interactions between docetaxel and doxorubicin against human breast and ovarian cancer cells.
Zeng S; Chen YZ; Fu L; Johnson KR; Fan W
Clin Cancer Res; 2000 Sep; 6(9):3766-73. PubMed ID: 10999771
[TBL] [Abstract][Full Text] [Related]
35. Taxoids in combination chemotherapy for metastatic breast cancer.
Dieras V; Fumoleau P; Bourgeois H; Misset JL; Azli N; Pouillart P
Anticancer Drugs; 1996 Aug; 7 Suppl 2():47-52. PubMed ID: 8862712
[TBL] [Abstract][Full Text] [Related]
36. Docetaxel.
Leahy M; Howell A
Br J Hosp Med; 1997 Feb 19-Mar 4; 57(4):141-4. PubMed ID: 9166374
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of 2'-methyl taxoids derived from baccatin III and 14beta-OH-baccatin III 1,14-carbonate.
Battaglia A; Bernacki RJ; Bertucci C; Bombardelli E; Cimitan S; Ferlini C; Fontana G; Guerrini A; Riva A
J Med Chem; 2003 Nov; 46(23):4822-5. PubMed ID: 14584931
[TBL] [Abstract][Full Text] [Related]
38. Preclinical evaluation of docetaxel (Taxotere).
Lavelle F; Bissery MC; Combeau C; Riou JF; Vrignaud P; André S
Semin Oncol; 1995 Apr; 22(2 Suppl 4):3-16. PubMed ID: 7740328
[TBL] [Abstract][Full Text] [Related]
39. Antitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and xenografted tumors.
Li C; Price JE; Milas L; Hunter NR; Ke S; Yu DF; Charnsangavej C; Wallace S
Clin Cancer Res; 1999 Apr; 5(4):891-7. PubMed ID: 10213226
[TBL] [Abstract][Full Text] [Related]
40. Overcoming multidrug resistance in taxane chemotherapy.
Geney R; Ungureanu lM; Li D; Ojima I
Clin Chem Lab Med; 2002 Sep; 40(9):918-25. PubMed ID: 12435109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]